Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomesVictòria Ceperuelo‐Mallafré, Sonia Fernández‐Veledo, Ezequiel Ruíz-Mateos et al.|Frontiers in Immunology|2022Cited by 17
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomesLaia Reverté, Elena Yeregui, Montserrat Olona et al.|Clinical and Translational Medicine|2022Cited by 16
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo‐Rodríguez, Luís F. López‐Cortés, Esperanza Muñoz‐Muela et al.|PLoS ONE|2022Cited by 5
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo‐Rodríguez, Luís F. López‐Cortés, Alicia Gutiérrez‐Valencia et al.|PLoS ONE|2024Cited by 0